Everolimus and Sunitinib in Pancreatic Neuroendocrine Tumors

0 Views
administrator
administrator
07/09/23

Diane Reidy-Lagunes, MD, MS, and Jonathan R. Strosberg, MD, review the efficacy and safety of sunitinib, and discuss some of the differences between sunitinib and everolimus.

To view more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next